The deadline for rheumatology teams to apply to the Aspiring to Excellence programme has now been extended to 18 September 2020. The programme is designed to encourage and recognise service improvement in axial SpA (AS) care and is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB.
There are six rheumatology teams from across the UK currently involved in the programme who are progressing with projects aimed at improving the quality of care for patients with axial SpA (AS.)…
Read more of this article